There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to ...

In the case of WW, analyst Linda Bolton Weiser assigned the stock a buy rating back in March, in a note framed around the question, "Why would an investor be interested in investing in WW, which ...